Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differential Impact of Plasma Proteins on the Adhesion Efficiency of Vascular-Targeted Carriers (VTCs) in Blood of Common Laboratory Animals.

Literature DB >> 26505780

Differential Impact of Plasma Proteins on the Adhesion Efficiency of Vascular-Targeted Carriers (VTCs) in Blood of Common Laboratory Animals.

Katawut Namdee¹, Daniel J Sobczynski¹, Peter J Onyskiw¹, Omolola Eniola-Adefeso¹.

Abstract

Vascular-targeted carrier (VTC) interaction with human plasma is known to reduce targeted adhesion efficiency in vitro. However, the role of plasma proteins on the adhesion efficiency of VTCs in laboratory animals remains unknown. Here, in vitro blood flow assays are used to explore the effects of plasma from mouse, rabbit, and porcine on VTC adhesion. Porcine blood exhibited a strong negative plasma effect on VTC adhesion while no significant plasma effect was found with rabbit and mouse blood. A brush density poly(ethylene glycol) (PEG) on VTCs was effective at improving adhesion of microsized, but not nanosized, VTCs in porcine blood. Overall, the results suggest that porcine models, as opposed to mouse, can serve as better models in preclinical research for predicting the in vivo functionality of VTCs for use in humans. These considerations hold great importance for the design of various pharmaceutical products and development of reliable drug delivery systems.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 26505780 PMCID： PMC4866610 DOI： 10.1021/acs.bioconjchem.5b00474

Source DB: PubMed Journal: Bioconjug Chem ISSN： 1043-1802 Impact factor: 4.774

53 in total

1. The human plasma proteome: a nonredundant list developed by combination of four separate sources.

Authors: N Leigh Anderson; Malu Polanski; Rembert Pieper; Tina Gatlin; Radhakrishna S Tirumalai; Thomas P Conrads; Timothy D Veenstra; Joshua N Adkins; Joel G Pounds; Richard Fagan; Anna Lobley
Journal: Mol Cell Proteomics Date: 2004-01-12 Impact factor: 5.911

2. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors: J L FAHEY; E M MCKELVEY
Journal: J Immunol Date: 1965-01 Impact factor: 5.422

3. Experimental atherosclerosis.

Authors: L N KATZ
Journal: Circulation Date: 1952-01 Impact factor: 29.690

4. Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins.

Authors: Peter Kingshott; Helmut Thissen; Hans J Griesser
Journal: Biomaterials Date: 2002-05 Impact factor: 12.479

5. Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammalian species: reference values and comparison of data.

Authors: U Windberger; A Bartholovitsch; R Plasenzotti; K J Korak; G Heinze
Journal: Exp Physiol Date: 2003-05 Impact factor: 2.969

6. Polymers bearing sLex-mimetics are superior inhibitors of E-selectin-dependent leukocyte rolling in vivo.

Authors: Majid Ali; Anne E R Hicks; Paul G Hellewell; Gebhard Thoma; Keith E Norman
Journal: FASEB J Date: 2003-11-03 Impact factor: 5.191

7. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.

Authors: Michael J Tolentino; Alexander J Brucker; Joshua Fosnot; Gui-Shuang Ying; I-Hui Wu; Gulraiz Malik; Shanhong Wan; Samuel J Reich
Journal: Retina Date: 2004-02 Impact factor: 4.256

Review 8. Of mice and not men: differences between mouse and human immunology.

Authors: Javier Mestas; Christopher C W Hughes
Journal: J Immunol Date: 2004-03-01 Impact factor: 5.422

9. Functional CT perfusion imaging in predicting the extent of cerebral infarction from a 3-hour middle cerebral arterial occlusion in a primate stroke model.

Authors: Leena M Hamberg; George J Hunter; Kenneth I Maynard; Chris Owen; Pearse P Morris; Christopher M Putman; Christopher Ogilvy; R Gilberto González
Journal: AJNR Am J Neuroradiol Date: 2002 Jun-Jul Impact factor: 3.825

10. Analysis of tight junctions during neutrophil transendothelial migration.

Authors: A R Burns; R A Bowden; S D MacDonell; D C Walker; T O Odebunmi; E M Donnachie; S I Simon; M L Entman; C W Smith
Journal: J Cell Sci Date: 2000-01 Impact factor: 5.285

9 in total

1. PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.

Authors: William J Kelley; Catherine A Fromen; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal: Acta Biomater Date: 2018-09-06 Impact factor: 8.947

2. Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow.

Authors: Daniel J Sobczynski; Omolola Eniola-Adefeso
Journal: Acta Biomater Date: 2016-10-17 Impact factor: 8.947

Review 3. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.

Authors: Violet V Sheffey; Emily B Siew; Eden E L Tanner; Omolola Eniola-Adefeso
Journal: Adv Healthc Mater Date: 2022-01-27 Impact factor: 11.092

4. Dual Coating of Chitosan and Albumin Negates the Protein Corona-Induced Reduced Vascular Adhesion of Targeted PLGA Microparticles in Human Blood.

Authors: Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal: Pharmaceutics Date: 2022-05-09 Impact factor: 6.525

Review 5. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors: William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2016-05-19

6. IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow.

Authors: Daniel J Sobczynski; Omolola Eniola-Adefeso
Journal: Bioeng Transl Med Date: 2017-05-22